Contribution of large genomic rearrangements in italian lynch syndrome patients: Characterization of a novel alu-mediated deletion

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Duraturo, Francesca ^a   Cavallo, Angela ^a   Liccardo, Raffaella ^a   Cudia, Bianca ^b   De Rosa, Marina ^a   Diana, Giuseppe ^b   Izzo, Paola ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; DNA BINDING PROTEIN; G-T MISMATCH-BINDING PROTEIN; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; G T MISMATCH BINDING PROTEIN;

ALU SEQUENCE; ARTICLE; EXON; GENE DELETION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC RECOMBINATION; GENOMICS; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; ITALY; MAJOR CLINICAL STUDY; POINT MUTATION; POLYMERASE CHAIN REACTION; CLINICAL TRIAL; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; GENETICS; MALE; MULTICENTER STUDY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALU ELEMENTS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA-BINDING PROTEINS; FEMALE; GENE REARRANGEMENT; HUMANS; ITALY; MALE; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; SEQUENCE DELETION;

EID: 84874604402     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/219897     Document Type: Article

References (36)

1. Carlomagno N., Pelosio L., Jamshidi A., Yabi M., Duraturo F., Izzo P., Renda A., The hereditary syndrome. ANDREA RENDA 2009 Milan, Italy Springe 107 128
2. Carlomagno N., Duraturo F., Rizzo G., Cremone C., Izzo P., Renda A., Renda A., Carcinogenesis. Multiple Primary Malignancies 2009 Milan, Italy Springer 51 61
3. Lynch P. M., The hMSH2 and hMLH1 genes in hereditary nonpolyposis colorectal cancer. Surgical Oncology Clinics of North America 2009 18 4 611 624 2-s2.0-70349305384 10.1016/j.soc.2009.08.002
4. Hendriks Y. M. C., Wagner A., Morreau H., Menko F., Stormorken A., Quehenberger F., Sandkuijl L., Møller P., Genuardi M., Van Houwelingen H., Tops C., Van Puijenbroek M., Verkuijlen P., Kenter G., Van Mil A., Meijers-Heijboer H., Tan G. B., Breuning M. H., Fodde R., Wijnen J. T. H., Bröcker-Vriends A. H. J. T., Vasen H., Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 2004 127 1 17 25 2-s2.0-3242670404 10.1053/j.gastro.2004.03.068 (Pubitemid 38962270)
5. Senter L., Clendenning M., Sotamaa K., Hampel H., Green J., Potter J. D., Lindblom A., Lagerstedt K., Thibodeau S. N., Lindor N. M., Young J., Winship I., Dowty J. G., White D. M., Hopper J. L., Baglietto L., Jenkins M. A., de la Chapelle A., The clinical phenotype of Lynch Syndrome due to germ-line PMS2 mutations. Gastroenterology 2008 135 2 419 428 2-s2.0-48549099663 10.1053/j.gastro.2008.04.026
6. Wu Y., Berends M. J. W., Sijmons R. H., Mensink R. G. J., Verlind E., Kooi K. A., Van Der Sluis T., Kempinga C., Van Der Zee A. G. J., Hollema H., Buys C. H. C. M., Kleibeuker J. H., Hofstra R. M. W., A role for MLH3 in hereditary nonpolyposis colorectal cancer. Nature Genetics 2001 29 2 137 138 2-s2.0-0034795933 10.1038/ng1001-137 (Pubitemid 32952647)
7. Duraturo F., Liccardo R., Cavallo A., Rosa M. D., Grosso M., Izzo P., Association of low-risk MSH3 and MSH2 variant alleles with Lynch syndrome: probability of synergistic effects. International Journal of Cancer 2011 129 7 1643 1650 2-s2.0-79960927829 10.1002/ijc.25824
8. Shah S. N., Hile S. E., Eckert K. A., Defective mismatch repair, microsatellite mutation bias, and variability in clinical cancer phenotypes. Cancer Research 2010 70 2 431 435 2-s2.0-76549111046 10.1158/0008-5472.CAN-09- 3049
9. Chong G., Jarry J., Marcus V., Thiffault I., Winocour S., Monczak Y., Drouin R., Latreille J., Australie K., Bapat B., Gordon P. H., Giguère Y., Gologan A., Galiatsatos P., Jass J. R., Wong N., Zaor S., Palma L., Kasprzak L., Tischkowitz M., Foulkes W. D., High frequency of exon deletions and putative founder effects in French Canadian Lynch Syndrome Families. Human Mutation 2009 30 8 E797 E812 2-s2.0-67749106239 10.1002/humu.21056
10. Martínez-Bouzas C., Ojembarrena E., Beristain E., Errasti J., Viguera N., Tejada Minguéz M. I., High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country. Cancer Letters 2007 255 2 295 299 2-s2.0-34547944364 10.1016/j.canlet.2007.05.004 (Pubitemid 47268646)
11. Castellví-Bel S., Castells A., Strunk M., Ferrández Á., Piazuelo E., Milà M., Piñol V., Rodríguez-Moranta F., Andreu M., Lanas Á., Piqué J. M., Genomic rearrangements in MSH2 and MLH1 are rare mutational events in Spanish patients with hereditary nonpolyposis colorectal cancer. Cancer Letters 2005 225 1 93 98 2-s2.0-21144444336 10.1016/j.canlet.2005.01.036 (Pubitemid 40732772)
12. Zavodna K., Krivulcik T., Bujalkova M. G., Slamka T., Martinicky D., Ilencikova D., Bartosova Z., Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers. BMC Cancer 2009 9, article 405 2-s2.0-71949098506 10.1186/1471-2407-9-405
13. Di Fiore F., Charbonnier F., Martin C., Frerot S., Olschwang S., Wang Q., Boisson C., Buisine M. P., Nilbert M., Lindblom A., Frebourg T., Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC. Journal of Medical Genetics 2004 41 1 18 20 2-s2.0-9144273165 (Pubitemid 38125681)
14. van der Klift H., Wijnen J., Wagner A., Verkuilen P., Tops C., Otway R., Kohonen-Corish M., Vasen H., Oliani C., Barana D., Moller P., DeLozier-Blanchet C., Hutter P., Foulkes W., Lynch H., Burn J., Möslein G., Fodde R., Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). Genes Chromosomes and Cancer 2005 44 2 123 138 2-s2.0-24944480082 10.1002/gcc.20219 (Pubitemid 41306641)
15. Kloor M., Sutter C., Wentzensen N., Cremer F. W., Buckowitz A., Keller M., von Knebel Doeberitz M., Gebert J., A large MHS2 Alu insertion mutation causes HNPCC in a German kindred. Human Genetics 2004 115 5 432 438 2-s2.0-5044252157 10.1007/s00439-004-1176-9 (Pubitemid 39341718)
16. Li L., McVety S., Younan R., Liang P., Du Sart D., Gordon P. H., Hutter P., Hogervorst F. B., Chong G., Foulkes W. D., Distinct patterns of germ-line deletions in MLH1 and MSH2: the implication of Alu repetitive element in the genetic etiology of Lynch syndrome (HNPCC). Human Mutation 2006 27 4 388 2-s2.0-33846673079
17. Aissi-Ben Moussa S., Moussa A., Lovecchio T., Kourda N., Najjar T., Ben Jilani S., El Gaaied A., Porchet N., Manai M., Buisine M. P., Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination. Familial Cancer 2009 8 2 119 126 2-s2.0-67349251552 10.1007/s10689-008-9215-7
18. Schouten J. P., McElgunn C. J., Waaijer R., Zwijnenburg D., Diepvens F., Pals G., Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Research 2002 30 12, article e57 2-s2.0-3543023204
19. Bunyan D. J., Eccles D. M., Sillibourne J., Wilkins E., Thomas S. J., Shea-Simonds J., Duncan P. J., Curtis C. E., Robinson D. O., Harvey J. F., Cross N. C. P., Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. British Journal of Cancer 2004 91 6 1155 1159 2-s2.0-5044227573 10.1038/sj.bjc.6602121 (Pubitemid 39336256)
20. Monzon J. G., Cremin C., Armstrong L., Nuk J., Young S., Horsman D. E., Garbutt K., Bajdik C. D., Gill S., Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer. International Journal of Cancer 2010 126 4 930 939 2-s2.0-74049157657 10.1002/ijc.24808
21. Schlegel J., Bocker T., Zirngabel H., Hofstadter F., Ruschoff J., Detection of microsatellite instability in human colorectal carcinomas using a non-radioactive PCR-based screening technique. Virchows Archiv 1995 426 3 223 227 2-s2.0-0029048049
22. Taylor C. F., Charlton R. S., Burn J., Sheridan E., Taylor G. R., Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA. Human Mutation 2003 22 6 428 433 2-s2.0-0346363771 10.1002/humu.10291 (Pubitemid 38009945)
23. Murphy K. M., Zhang S., Geiger T., Hafez M. J., Bacher J., Berg K. D., Eshleman J. R., Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. Journal of Molecular Diagnostics 2006 8 3 305 311 2-s2.0-33745977120 10.2353/jmoldx.2006.050092 (Pubitemid 44063806)
24. Juretic N., Bureau T. E., Bruskiewich R. M., Transposable element annotation of the rice genome. Bioinformatics 2004 20 2 155 160 2-s2.0-1042280956 10.1093/bioinformatics/bth019 (Pubitemid 38195672)
25. Charbonnier F., Olschwang S., Wang Q., Boisson C., Martin C., Buisine M. P., Puisieux A., Frebourg T., MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Research 2002 62 3 848 853 2-s2.0-0036468254 (Pubitemid 34126963)
26. Wijnen J., Van der Klift H., Vasen H. F. A., Khan P. M., Menko F., Tops C., Heijboer H. M., Lindhout D., Moller P., Fodde R., MSH2 genomic deletions are a frequent cause of HNPCC. Nature Genetics 1998 20 4 326 328 2-s2.0-0031795020 10.1038/3795 (Pubitemid 28541626)
27. Charbonnier F., Baert-Desurmont S., Liang P., Di Fiore F., Martin C., Frerot S., Olschwang S., Wang Q., Buisine M. P., Gilbert B., Nilbert M., Lindblom A., Frebourg T., The 5′ region of the MSH2 gene involved in hereditary non-polyposis colorectal cancer contains a high density of recombinogenic sequences. Human Mutation 2005 26 3 255 261 2-s2.0-24344494026 10.1002/humu.20216 (Pubitemid 41258185)
28. Wang Y., Friedl W., Lamberti C., Jungck M., Mathiak M., Pagenstecher C., Propping P., Mangold E., Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes. International Journal of Cancer 2003 103 5 636 641 2-s2.0-0037455807 10.1002/ijc.10869 (Pubitemid 36091467)
29. Gylling A., Ridanpää M., Vierimaa O., Aittomäki K., Avela K., Kääriäinen H., Laivuori H., Pöyhönen M., Sallinen S. L., Wallgren-Pettersson C., Järvinen H. J., Mecklin J. P., Peltomäki P., Large genomic rearrangements and germline epimutations in Lynch syndrome. International Journal of Cancer 2009 124 10 2333 2340 2-s2.0-64249108224 10.1002/ijc.24230
30. Kang P., Mariapun S., Phuah S. Y., Lim L. S., Liu J., Yoon S. Y., Thong M. K., Mohd Taib N. A., Yip C. H., Teo S. H., Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families. Breast Cancer Research and Treatment 2010 124 2 579 584 2-s2.0-78649317049 10.1007/s10549-010-1018-5
31. De Rosa M., Galatola M., Quaglietta L., Miele E., De Palma G., Rossi G. B., Staiano A., Izzo P., Alu-mediated genomic deletion of the serine/threonine protein kinase 11 (STK11) gene in peutz-jeghers syndrome. Gastroenterology 2010 138 7 2558 2560 2-s2.0-77952692649 10.1053/j.gastro.2010.03.061
32. Martinez S. L., Kolodner R. D., Functional analysis of human mismatch repair gene mutations identifies weak alleles and polymorphisms capable of polygenic interactions. Proceedings of the National Academy of Sciences of the United States of America 2010 107 11 5070 5075 2-s2.0-77950452745 10.1073/pnas.1000798107
33. Lynch H. T., Lynch J. F., Snyder C. L., Riegert-Johnson D., EPCAM deletions, Lynch syndrome, and cancer risk. The Lancet Oncology 2011 12 1 5 6 2-s2.0-78650713193 10.1016/S1470-2045(10)70291-6
34. De Rosa M., Galatola M., Borriello S., Duraturo F., Masone S., Izzo P., Implication of adenomatous polyposis coli and MUTYH mutations in familial colorectal polyposis. Diseases of the Colon and Rectum 2009 52 2 268 274 2-s2.0-64049111658 10.1007/DCR.0b013e318197d15c
35. Bläker H., Mechtersheimer G., Sutter C., Hertkorn C., Kern M. A., Rieker R. J., Penzel R., Schirmacher P., Kloor M., Recurrent deletions at 6q in early age of onset non-HNPCC- and non-FAP-associated intestinal carcinomas. Evidence for a novel cancer susceptibility locus at 6q14-q22. Genes Chromosomes and Cancer 2008 47 2 159 164 2-s2.0-38049051401 10.1002/gcc.20516
36. Fitzgerald L. M., McDonnell S. K., Carlson E. E., Langeberg W., McIntosh L. M., Deutsch K., Ostrander E. A., Schaid D. J., Stanford J. L., Genome-wide linkage analyses of hereditary prostate cancer families with colon cancer provide further evidence for a susceptibility locus on 15q11-q14. European Journal of Human Genetics 2010 18 10 1141 1147 2-s2.0-77957105586 10.1038/ejhg.2010.49